Related Experiment Video
Updated: Jul 11, 2026
11:14
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
Published on: November 10, 2013
CE in anticancer metallodrug research--an update.
Christian G Hartinger1, Bernhard K Keppler
1Institute of Inorganic Chemistry, University of Vienna, Waehringer Strasse 42, A-1090 Vienna, Austria. christian.hartinger@univie.ac.at
Electrophoresis
|September 12, 2007
Summary
Capillary electrophoresis (CE) advances metallodrug research for cancer chemotherapy. New applications study metal complex interactions with proteins and redox reactions, aiding new anticancer drug design.
Area of Science:
- Analytical Chemistry
- Medicinal Chemistry
- Biochemistry
Background:
- Cancer chemotherapy requires novel treatment options due to increasing cancer incidence with age.
- Metal-based drugs are a promising area for cancer treatment.
- Capillary electrophoretic (CE) methods have been used to study metal-based drugs and drug candidates.
Purpose of the Study:
- To review developments in metallodrug research using CE over the last 4 years.
- To highlight the expanding applications of CE in understanding metallodrug mechanisms.
- To discuss future directions for CE in anticancer drug design.
Main Methods:
- Review of recent literature (last 4 years) on CE applications in metallodrug research.
- Analysis of studies focusing on protein-metal complex binding, redox reactions, and reactivity.
- Examination of advanced CE techniques like microemulsion EKC, ACE, and hyphenation with mass spectrometry (ICP-MS, ESI-MS).
Main Results:
- CE applications have broadened significantly, including binding studies of metal complexes to proteins and determination of kinetic parameters.
- CE is used to monitor redox reactions of metal complexes and their impact on biological targets.
- Hyphenation with mass spectrometry (ICP-MS, ESI-MS) enables detailed analysis of protein metallation and adduct characterization.
Conclusions:
- CE is a powerful tool for advancing metallodrug research and understanding anticancer mechanisms.
- Continued methodological development and application to real-world samples will enhance CE's contribution to new anticancer agent design.
- Future research should focus on new cellular targets and improved analytical methodologies.
More Related Videos
05:36Quantifiable and Inexpensive Cell-Free Fluorescent Method to Confirm the Ability of Novel Compounds to Chelate Iron
Published on: February 23, 2024
07:20Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
Related Concept Videos
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.